DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: However, the existence of dystroglycan complexes independent of the DAPC would imply that additional disease mechanisms may be involved in the highly variable clinical phenotype of dystroglycanopathies, with important implications for treatment avenues.